India

Remdesivir For COVID-19 Patients To Be Sold As Remdac At Rs 2,800 Per Vial

Remdesivir has been launched under the brand name Remdac in the Indian market. Meant to treat patients suffering from severe symptoms of COVID-19, it will be priced at Rs 2,800 per 100 mg vial.

Remdac is the most economical Remdesivir brand in India, the manufacturing company Zydus Cadila was quoted as saying by Hindustan Times (HT).

The company said the drug will be made available across India through the group’s strong distribution chain reaching out to government and private hospitals treating COVID-19 patients.

“Remdac is the most affordable drug as we would like to enable patients to have access to this critical drug in the treatment of Covid-19,” Cadila Healthcare Managing Director Dr. Sharvil Patel was quoted as saying by HT. 

OB Bureau

Recent Posts

When A ‘Powerful Man’s Wife’ Broke Into Varun Dhawan’s House To Elope With Actor!

Mumbai: Bollywood celebrities have often had funny, at times bizarre experiences, mostly involving hero-worshipping, demanding fans.…

10 hours ago

Jatra Party Owner Arrested For Duping Actress Of Over Rs 8 Lakh In Bhubanewar

Bhubaneswar: Police have arrested the owner of a Jatra (theatre) group for allegedly duping an…

10 hours ago

How Punjab Farmers Have Paved The Way For Revival Of Organic Desi Cotton

Sanskriti Talwar Faridkot (Punjab): For the third consecutive year, Balwinder Singh of Mallan village in…

10 hours ago

Rain May Play Spoilsport During Christmas & New Year Celebrations In Odisha

Bhubaneswar: Rain may play spoilsport in Christmas and New Year celebrations in Odisha as the…

11 hours ago

Now, Amazon Prime Cracks Down On Password Sharing; Check Out Details Here

New Delhi: Netflix showed the way, Amazon Prime Video is following in their footsteps. Come…

11 hours ago

[Watch] Allu Arjun’s House Vandalised By Protesters Over ‘Pushpa 2’ Stampede; Know Their Demands

Hyderabad: Allu Arjun’s woes keep mounting. In a worrying development, protesters stormed Allu Arjun’s Jubilee…

11 hours ago

This website uses cookies.